Cover Image
Market Research Report

Human Vaccines

Published by Global Industry Analysts, Inc. Product code 236754
Published Content info 158 Pages
Delivery time: 1-2 business days
Price
Back to Top
Human Vaccines
Published: February 1, 2020 Content info: 158 Pages
Description

Human Vaccines market worldwide is projected to grow by US$14.6 Billion, driven by a compounded growth of 6.1%. Pediatric, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$24.7 Billion by the year 2025, Pediatric will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 5.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$516.6 Million to the region's size and clout in the next 5 to 6 years. Over US$446.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Pediatric will reach a market size of US$1.3 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9% over the next couple of years and add approximately US$3.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • ALK - Abello A/S
  • Altimmune, Inc.
  • Astellas Pharma Inc.
  • Bavarian Nordic A/S
  • BiondVax Pharmaceuticals Ltd.
  • Bharat Biotech
  • GlaxoSmithKline Plc.
  • Hualan Biological Engineering Inc.
  • Janssen Pharmaceuticals Inc.
  • MedImmune
  • Merck Sharp & Dohme Corp.
  • Mitsubishi Tanabe Pharma
  • Pfizer Inc.
  • Sanofi Pasteur SA
  • Serum Institute of India Pvt. Ltd.
  • Seqirus
  • SK BioScience
  • Takeda Pharmaceutical Company Limited
  • Zydus Cadila

Table of Contents
Product Code: MCP-1176

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Human Vaccines: A Prelude
  • Recent Market Activity
  • Competitive Scenario
  • Vaccine Pricing: A Review
  • Global Competitor Market Shares
  • Human Vaccines Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

  • ALK - Abello A/S (Denmark)
  • Altimmune, Inc. (USA)
  • Astellas Pharma Inc. (Tokyo)
  • Bavarian Nordic (Denmark)
  • BiondVax Pharmaceuticals Ltd. (Israel)
  • Bharat Biotech (India)
  • GlaxoSmithKline Plc. (UK)
  • Hualan Biological Engineering Inc. (China)
  • Janssen Pharmaceuticals, Inc. (USA)
  • MedImmune (USA)
  • Merck Sharp & Dohme Corp., (USA)
  • Mitsubishi Tanabe Pharma Corporate (Japan)
  • Pfizer, Inc. (USA)
  • Sanofi Pasteur SA (France)
  • Serum Institute of India Pvt. Ltd. (India)
  • Seqirus (UK)
  • SK BioScience (Korea)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Zydus Cadila (India)

3. MARKET TRENDS & DRIVERS

  • Combination Vaccines Market Driven by Fast Expanding Pediatric Population
  • List of Combination Vaccines in the US: 2018
  • Gardasil 9 Offers Protection against HPV for Expanded Age Group
  • Increasing Demand for Recombinant Vaccines
  • Global Cholera Vaccines Market
  • Further Clinical Trials Needed for an Effective Zika Vaccine
  • Merck's rVSV-ZEBOV Ebola Vaccine used for Ring Vaccination in Congo
  • Rising Dengue Cases Drive Vaccines Demand
  • Sanofi's Dengue Vaccine First-to-Market
  • EMA Recommends Approval of Dengue Vaccine
  • Vaccine for AIDS
  • Staggering Global Statistics of AIDS - Opportunity Indicator
  • Toxoid Vaccines Market
  • H1N1 Vaccines Market
  • HSV Vaccine on the Horizon
  • Rising Disease Incidence and Increasing Awareness Drive the Global Meningococcal Vaccines Market
  • BCG Vaccines
  • Key TB Vaccine Candidates in the Pipeline: 2018
  • New Vaccine for Herpes Zoster or Shingles
  • Two-dose Hepatitis B Vaccine for Adults
  • Global Rotavirus Vaccines Market
  • Typhoid Vaccines Market
  • Measles Vaccines Market
  • DNA Vaccines: Engineering Growth
  • Mobile Money Encourages Parents for Vaccinating Children
  • Noninjectable Vaccines: Gain without Pain
  • Application of Botulinum Toxin as Delivery Mechanism for Oral Vaccines
  • Novel Technologies Ensure Timely Vaccine Delivery for Patients in Remote Locations
  • Smart mRNA Vaccines
  • Growing Pricing Pressure - A Major Market Deterrent
  • Safety Issues Come to the Fore
  • Novel Vaccination Guidelines Mitigate Risks Associated with Developing Shoulder Injuries
  • BioWarfare: Threat Perception and Preparedness
  • Overview of Potential Bio-Terrorist Agents
  • Smallpox (Variola Major)
  • Anthrax (Bacillus Anthracis)
  • Plague (Yersinia Pestis)
  • Botulism (Clostridium Botulinum)
  • Tularemia (Francisella Tularensis)
  • Tackling Cold Chain Issues
  • Trade Statistics
  • Growing Incidence of Infectious Diseases Drives the Global Human Vaccines Market
  • Total Number of Infectious Disease Covered under Vaccination
  • Conjugate Vaccines Rule in Human Vaccines Market
  • Pneumococcal Vaccines - A Major Segment
  • Vaccine Pipeline by Major Companies
  • GSK Vaccine Pipeline
  • Merck Vaccines Pipeline
  • Pfizer Vaccines Pipeline
  • Sanofi Vaccines Portfolio
  • Emergent BioSolutions Inc. - Vaccine Pipeline
  • Astellas Pharma - Vaccines
  • Pediatric Vaccines Dominate the Human Vaccines Market
  • Select Pediatric Vaccines
  • Adults Vaccine Market to Witness Rapid Growth, Driven by Government Initiatives
  • Select Adult Vaccines
  • Developed Markets Dominate, Emerging Regions to Exhibit the Fastest Growth
  • Pneumococcal Vaccines Market Set to Witness Rapid Growth
  • Influenza Vaccines Market: A High Growth Segment
  • Cancer Vaccines Market Offers Potential Opportunities

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Human Vaccines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Human Vaccines Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Human Vaccines Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Pediatric (Product Segment) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Pediatric (Product Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Pediatric (Product Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Adult (Product Segment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Adult (Product Segment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Adult (Product Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Human Vaccines Market Share (in %) by Company: 2020 & 2025
    • Market Analytics
    • TABLE 10: United States Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025
    • TABLE 11: Human Vaccines Market in the United States by Product Segment: A Historic Review in US$ Million for 2009-2017
    • TABLE 12: United States Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 13: Canadian Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025
    • TABLE 14: Canadian Human Vaccines Historic Market Review by Product Segment in US$ Million: 2009-2017
    • TABLE 15: Human Vaccines Market in Canada: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025
  • JAPAN
    • TABLE 16: Japanese Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 17: Human Vaccines Market in Japan: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017
    • TABLE 18: Japanese Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 19: Chinese Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 20: Human Vaccines Historic Market Analysis in China in US$ Million by Product Segment: 2009-2017
    • TABLE 21: Chinese Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Human Vaccines Market: Competitor Market Share Scenario (in %) for 2020 & 2025
    • Market Analytics
    • TABLE 22: European Human Vaccines Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 23: Human Vaccines Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 24: European Human Vaccines Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 25: European Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025
    • TABLE 26: Human Vaccines Market in Europe in US$ Million by Product Segment: A Historic Review for the Period 2009-2017
    • TABLE 27: European Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 28: Human Vaccines Market in France by Product Segment: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 29: French Human Vaccines Historic Market Scenario in US$ Million by Product Segment: 2009-2017
    • TABLE 30: French Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 31: Human Vaccines Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 32: German Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017
    • TABLE 33: German Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 34: Italian Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 35: Human Vaccines Historic Market Analysis in Italy in US$ Million by Product Segment: 2009-2017
    • TABLE 36: Italian Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 37: United Kingdom Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 38: Human Vaccines Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017
    • TABLE 39: United Kingdom Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 40: Spanish Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025
    • TABLE 41: Spanish Human Vaccines Historic Market Review by Product Segment in US$ Million: 2009-2017
    • TABLE 42: Human Vaccines Market in Spain: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 43: Russian Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025
    • TABLE 44: Human Vaccines Market in Russia by Product Segment: A Historic Review in US$ Million for 2009-2017
    • TABLE 45: Russian Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025
    • TABLE 47: Human Vaccines Market in Rest of Europe in US$ Million by Product Segment: A Historic Review for the Period 2009-2017
    • TABLE 48: Rest of Europe Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 49: Asia-Pacific Human Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 50: Human Vaccines Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 51: Asia-Pacific Human Vaccines Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 52: Human Vaccines Market in Asia-Pacific by Product Segment: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 53: Asia-Pacific Human Vaccines Historic Market Scenario in US$ Million by Product Segment: 2009-2017
    • TABLE 54: Asia-Pacific Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 55: Human Vaccines Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 56: Australian Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017
    • TABLE 57: Australian Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 58: Indian Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025
    • TABLE 59: Indian Human Vaccines Historic Market Review by Product Segment in US$ Million: 2009-2017
    • TABLE 60: Human Vaccines Market in India: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 61: Human Vaccines Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 62: South Korean Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017
    • TABLE 63: Human Vaccines Market Share Distribution in South Korea by Product Segment: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 64: Rest of Asia-Pacific Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 65: Human Vaccines Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017
    • TABLE 66: Rest of Asia-Pacific Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 67: Latin American Human Vaccines Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 68: Human Vaccines Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 69: Latin American Human Vaccines Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 70: Latin American Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 71: Human Vaccines Historic Market Analysis in Latin America in US$ Million by Product Segment: 2009-2017
    • TABLE 72: Latin American Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 73: Argentinean Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025
    • TABLE 74: Human Vaccines Market in Argentina in US$ Million by Product Segment: A Historic Review for the Period 2009-2017
    • TABLE 75: Argentinean Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 76: Human Vaccines Market in Brazil by Product Segment: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 77: Brazilian Human Vaccines Historic Market Scenario in US$ Million by Product Segment: 2009-2017
    • TABLE 78: Brazilian Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 79: Human Vaccines Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 80: Mexican Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017
    • TABLE 81: Mexican Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 82: Rest of Latin America Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025
    • TABLE 83: Human Vaccines Market in Rest of Latin America by Product Segment: A Historic Review in US$ Million for 2009-2017
    • TABLE 84: Rest of Latin America Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 85: The Middle East Human Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 86: Human Vaccines Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 87: The Middle East Human Vaccines Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 88: The Middle East Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018 to 2025
    • TABLE 89: The Middle East Human Vaccines Historic Market by Product Segment in US$ Million: 2009-2017
    • TABLE 90: Human Vaccines Market in the Middle East: Percentage Share Breakdown of Sales by Product Segment for 2009, 2019, and 2025
  • IRAN
    • TABLE 91: Iranian Market for Human Vaccines: Annual Sales Estimates and Projections in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 92: Human Vaccines Market in Iran: Historic Sales Analysis in US$ Million by Product Segment for the Period 2009-2017
    • TABLE 93: Iranian Human Vaccines Market Share Analysis by Product Segment: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 94: Israeli Human Vaccines Market Estimates and Forecasts in US$ Million by Product Segment: 2018-2025
    • TABLE 95: Human Vaccines Market in Israel in US$ Million by Product Segment: A Historic Review for the Period 2009-2017
    • TABLE 96: Israeli Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 97: Saudi Arabian Human Vaccines Market Growth Prospects in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 98: Human Vaccines Historic Market Analysis in Saudi Arabia in US$ Million by Product Segment: 2009-2017
    • TABLE 99: Saudi Arabian Human Vaccines Market by Product Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 100: Human Vaccines Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 101: United Arab Emirates Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017
    • TABLE 102: Human Vaccines Market Share Distribution in United Arab Emirates by Product Segment: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 103: Human Vaccines Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product Segment for the Period 2018-2025
    • TABLE 104: Rest of Middle East Human Vaccines Historic Market Analysis in US$ Million by Product Segment: 2009-2017
    • TABLE 105: Rest of Middle East Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 106: African Human Vaccines Market Estimates and Projections in US$ Million by Product Segment: 2018 to 2025
    • TABLE 107: Human Vaccines Market in Africa by Product Segment: A Historic Review in US$ Million for 2009-2017
    • TABLE 108: African Human Vaccines Market Share Breakdown by Product Segment: 2009 VS 2019 VS 2025

IV. COMPETITION

  • Total Companies Profiled: 66
  • HUMAN VACCINES MCP-1176
  • CONTENTS
Back to Top